This is tuberculosis that affects the heart and blood vessels. It's caused by the same germ that causes lung tuberculosis, Mycobacterium tuberculosis. It can lead to serious heart problems.
Every report comes from a Lived member, sent anonymously.
Have you tried Isoniazid for Cardiovascular Tuberculosis?
Cardiovascular tuberculosis is tuberculosis (TB) infection that affects the heart or blood vessels. By far the most common form is tuberculous pericarditis, an infection of the pericardium, the thin two-layered sac that surrounds the heart. The infection inflames the sac and often makes fluid collect inside it. That fluid can press on the heart and keep it from filling properly, which is why the condition typically causes breathlessness, tiredness and swelling of the legs or abdomen, often alongside general TB symptoms such as fever, night sweats and weight loss. Over time, the inflamed pericardium can thicken and scar. When it stiffens enough to squeeze the heart, the result is constrictive pericarditis, a long-term form of heart failure. Much rarer forms of cardiovascular TB infect the heart muscle itself (tuberculous myocarditis), which can disturb the heart's rhythm, or the wall of the aorta, the body's main artery, where it can weaken the wall and form a bulge (aneurysm) at risk of bursting. In the United States and other countries where TB is uncommon, pericardial TB is rare. In parts of Africa and Asia where TB and HIV are common, it is a leading cause of fluid around the heart.
The cause is Mycobacterium tuberculosis, the same bacterium that causes lung TB. It spreads through the air when someone with TB in the lungs or throat coughs, sneezes or talks. After infection, the bacteria can stay dormant for years, then become active and travel through the lymph system or bloodstream to the pericardium. Sometimes the heart is the only place the infection shows up, with no obvious lung disease. The main risk factors are those that make active TB more likely or bring someone into contact with it: having HIV (the most important factor where both infections are common), having lived in or often traveled to a country where TB is widespread, and taking medicines that weaken the immune system, such as long-term steroids, drugs used after an organ transplant or biologic treatments for autoimmune diseases. Kidney failure, particularly on dialysis, diabetes and alcohol or drug use disorders also raise the risk.
The first step is usually an echocardiogram, an ultrasound of the heart that shows whether fluid has collected around it and whether that fluid is pressing on the heart. A chest X-ray may show an enlarged heart outline or signs of TB in the lungs, and a CT or MRI scan can measure how thick the pericardium has become or reveal swollen lymph nodes in the chest. Confirming that TB is the cause is harder. When there is enough fluid, a doctor removes some with a needle (pericardiocentesis) and tests it for TB bacteria and their genetic material, and for markers of TB-related inflammation such as adenosine deaminase (ADA), an enzyme that is high in TB fluid. Growing TB from the fluid in a lab culture is the most definitive test, but it misses a substantial share of cases and takes at least three weeks. Sometimes a small sample of the pericardium itself is taken for testing. Because no single test settles every case, doctors often make a probable diagnosis from the combination of findings, especially when TB is found elsewhere in the body, and start treatment without waiting for culture results. TB skin and blood tests show past exposure but cannot tell whether the heart is infected. Anyone diagnosed with TB pericarditis should also be tested for HIV, since it changes the treatment plan.
The core of treatment is a combination of TB antibiotics taken daily. For drug-sensitive TB, this usually means four medicines, rifampin (also called rifampicin), isoniazid, pyrazinamide and ethambutol, for the first two months, then rifampin and isoniazid for four more months, six months in all. Taking every dose for the full course matters: stopping early or skipping doses can let the bacteria survive and become resistant, which leads to longer and harder treatment. TB that is resistant to standard drugs needs a different regimen chosen by a specialist. Treatment usually begins in the hospital, and a health department nurse may help by watching doses being taken. If fluid is pressing on the heart, it is drained with a needle passed under the breastbone using ultrasound or X-ray guidance. If fluid keeps coming back or cannot be reached safely, a surgeon may drain it through a small opening instead. Corticosteroids such as prednisolone, anti-inflammatory steroid medicines, are sometimes added for about six weeks. In large trials they lowered the chance of developing constriction and of returning to hospital, and in people without HIV they probably reduce deaths from pericarditis, but they did not clearly improve overall survival. In people with HIV who were not yet on HIV treatment, steroids were linked to more HIV-related cancers. US guidelines therefore advise against using them routinely and reserve them for people at highest risk of complications, such as those with large effusions or early signs of constriction. People with HIV also start antiretroviral therapy during TB treatment. If constrictive pericarditis develops and does not improve with medicine, the treatment is pericardiectomy, surgery to remove the stiffened pericardium. It can relieve symptoms substantially but is major heart surgery with a meaningful risk, and outcomes depend on the center's experience. Tuberculous aortic aneurysms usually need surgical or stent-graft repair along with TB medicines.
Tuberculous pericarditis is a serious illness, and outcomes depend heavily on how early treatment starts and on overall health, particularly HIV status and how advanced it is. Many people recover well with a full course of treatment, but deaths still occur, mostly in places with limited access to care and among people with advanced HIV. The six months of treatment are a real commitment. Most people take pills daily and have regular check-ups, blood tests to watch for liver effects of the TB drugs, and repeat echocardiograms to see whether the fluid is clearing. Rifampin interacts with many other medicines, including some HIV medicines, blood thinners and hormonal birth control, so every prescriber needs to know about it. Energy and breathing often improve over weeks once fluid is drained and the infection is controlled. The main long-term concern is constriction. In recent studies roughly 5 to 25 percent of people developed constrictive pericarditis, sometimes months after treatment began. For this reason follow-up continues through and after treatment, looking for returning breathlessness or swelling. TB confined to the pericardium is not generally passed to others, but if the lungs or throat are also infected, people may need to stay home for the first weeks of treatment and close contacts may be tested.
Ask for a medical evaluation if you have ongoing breathlessness, swelling of the legs or belly, or chest discomfort together with fever, night sweats or unexplained weight loss, especially if you have HIV, take immune-suppressing medicines or have lived where TB is common. During or after treatment, contact your care team promptly if breathlessness or swelling returns or worsens, if you cannot keep taking your TB medicines, or if you develop yellowing skin or eyes, dark urine or persistent nausea, which can signal liver irritation from the drugs. Fluid around the heart can build up to the point of cardiac tamponade, an emergency. Call 911 for severe or rapidly worsening shortness of breath, fainting or near-fainting, or chest pain with pale, gray or clammy skin.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Cardiovascular Tuberculosis is like, what's helped you, or ask the community a question.